Clinical Trial Update: Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether butylphthalide reduces restenosis after intracranial and extracranial artery stenting; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extracranial Artery Stenosis
• Intracranial Artery Stenosis
• Restenosis

Drugs mentioned

• Butylphthalide (butylphthalide)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Restenosis | Phase 3 | Status: COMPLETED